# FLUDEOXYGLUCOSE F18
> **ANDA216125** · Abbreviated New Drug Application (Generic) · Sponsor: BAMF · Approved 2025-03-11
## Drug
- **FDA Application Number:** ANDA216125
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FLUDEOXYGLUCOSE F18
- **Generic name:** FLUDEOXYGLUCOSE F-18
- **Active ingredients:** FLUDEOXYGLUCOSE F-18
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BAMF
- **Manufacturer:** BAMF Health Inc.
- **First approval:** 2025-03-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216125)
---
*AI Analytics · CC0 1.0*